186 related articles for article (PubMed ID: 9376590)
1. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation.
Gallego MD; Santamaría M; Peña J; Molina IJ
Blood; 1997 Oct; 90(8):3089-97. PubMed ID: 9376590
[TBL] [Abstract][Full Text] [Related]
2. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction.
Wada T; Jagadeesh GJ; Nelson DL; Candotti F
Hum Gene Ther; 2002 Jun; 13(9):1039-46. PubMed ID: 12067437
[TBL] [Abstract][Full Text] [Related]
4. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome.
Molina IJ; Kenney DM; Rosen FS; Remold-O'Donnell E
J Exp Med; 1992 Sep; 176(3):867-74. PubMed ID: 1512549
[TBL] [Abstract][Full Text] [Related]
5. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses.
Molina IJ; Sancho J; Terhorst C; Rosen FS; Remold-O'Donnell E
J Immunol; 1993 Oct; 151(8):4383-90. PubMed ID: 8409409
[TBL] [Abstract][Full Text] [Related]
6. A role for Wiskott-Aldrich syndrome protein in T-cell receptor-mediated transcriptional activation independent of actin polymerization.
Silvin C; Belisle B; Abo A
J Biol Chem; 2001 Jun; 276(24):21450-7. PubMed ID: 11283014
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements.
Sato M; Tsuji NM; Gotoh H; Yamashita K; Hashimoto K; Tadotsu N; Yamanaka H; Sekikawa K; Hashimoto Y
J Immunol; 2001 Oct; 167(8):4701-9. PubMed ID: 11591801
[TBL] [Abstract][Full Text] [Related]
8. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
9. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
[TBL] [Abstract][Full Text] [Related]
10. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation.
Snapper SB; Rosen FS; Mizoguchi E; Cohen P; Khan W; Liu CH; Hagemann TL; Kwan SP; Ferrini R; Davidson L; Bhan AK; Alt FW
Immunity; 1998 Jul; 9(1):81-91. PubMed ID: 9697838
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Wiskott-Aldrich syndrome protein and other actin regulatory adaptors in T cell activation.
Badour K; Zhang J; Siminovitch KA
Semin Immunol; 2004 Dec; 16(6):395-407. PubMed ID: 15541654
[TBL] [Abstract][Full Text] [Related]
12. Waltzing with WASP.
Ramesh N; Antón IM; Martínez-Quiles N; Geha RS
Trends Cell Biol; 1999 Jan; 9(1):15-9. PubMed ID: 10087612
[TBL] [Abstract][Full Text] [Related]
13. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells.
Andreu N; Aran JM; Fillat C
Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274
[TBL] [Abstract][Full Text] [Related]
14. The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse.
Badour K; Zhang J; Shi F; McGavin MK; Rampersad V; Hardy LA; Field D; Siminovitch KA
Immunity; 2003 Jan; 18(1):141-54. PubMed ID: 12530983
[TBL] [Abstract][Full Text] [Related]
15. Wiskott-Aldrich Syndrome causing mutation, Pro373Ser restricts conformational changes essential for WASP activity in T-cells.
Jain N; George B; Thanabalu T
Biochim Biophys Acta; 2014 Apr; 1842(4):623-34. PubMed ID: 24440360
[TBL] [Abstract][Full Text] [Related]
16. Contributions of Wiskott-Aldrich syndrome family cytoskeletal regulatory adapters to immune regulation.
Zhang J; Dong B; Siminovitch KA
Immunol Rev; 2009 Nov; 232(1):175-94. PubMed ID: 19909364
[TBL] [Abstract][Full Text] [Related]
17. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
Huang W; Ochs HD; Dupont B; Vyas YM
J Immunol; 2005 Mar; 174(5):2602-11. PubMed ID: 15728466
[TBL] [Abstract][Full Text] [Related]
18. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells.
Rengan R; Ochs HD; Sweet LI; Keil ML; Gunning WT; Lachant NA; Boxer LA; Omann GM
Blood; 2000 Feb; 95(4):1283-92. PubMed ID: 10666201
[TBL] [Abstract][Full Text] [Related]
19. Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells.
Parsey MV; Lewis GK
J Immunol; 1993 Aug; 151(4):1881-93. PubMed ID: 7688389
[TBL] [Abstract][Full Text] [Related]
20. Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation.
Bouma G; Burns SO; Thrasher AJ
Immunobiology; 2009; 214(9-10):778-90. PubMed ID: 19628299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
